Yes.
I appreciate your efforts to get at the truth.
Something I did not mention is the radical transformation in Revenue Recognition.
I see NAN as trying to move to an Annuity type Revenue . Hospitals and other places of healthcare provision are on tight budgets with the capital costs of healthcare ballooning.
NAN is responding with a variety of Revenue Models. I counted 5.
The main emphasis is on NOT selling Trophon directly. NAN keepits capital costs on the BS and depreciates. Instead the revenue comes from consumables and annual services.
An under reported feature of the Mr Trump tax cuts is the instantaneous write off of capital expenses. And this may encourage the sale of Trophons. NAN has many ways to get revenue.
- Forums
- ASX - By Stock
- NAN
- Ann: Appendix 4D and Half Year Report
Ann: Appendix 4D and Half Year Report, page-29
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.59 |
Change
-0.060(1.64%) |
Mkt cap ! $1.089B |
Open | High | Low | Value | Volume |
$3.65 | $3.68 | $3.57 | $1.250M | 344.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2910 | $3.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.62 | 447 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2910 | 3.570 |
3 | 6150 | 3.560 |
2 | 3357 | 3.550 |
2 | 3409 | 3.540 |
2 | 3409 | 3.530 |
Price($) | Vol. | No. |
---|---|---|
3.620 | 447 | 1 |
3.630 | 447 | 1 |
3.640 | 3357 | 2 |
3.650 | 3357 | 2 |
3.660 | 3357 | 2 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
NAN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online